Abstract. Angiomyolipoma (AML) is a benign mesenchymal tumor composed of variable proportions of adipose tissue, spindle and epithelioid smooth muscle cells and abnormal thick-walled blood vessels. Approximately one-third of epithelioid AML (EAML) cases have been reported to have metastasis. Thus, it would be of interest to identify the adverse pathological parameters correlated with outcome. However, few studies have been conducted on large numbers of samples. The aim of this study was to highlight the clinicopathological features of AML and the morphological features of EAML, which were correlated with malignant behaviors in patients from a single institutional series analysis. One hundred and fifty-six consecutive AMLs, correlating with pathological characteristics, were analyzed between 1981 and 2010. The Chi-square test was performed to clarify the significance of the clinicopathological factors among the regular and epithelioid subtypes with or without atypia. The two organs most commonly involved were the kidney (77%, 120/156) and liver (14%, 22/156). Of the 156 AMLs, EAMLs (17.3%, 27/156) had more marked mitosis, hemorrhage and multinucleated giant cells compared with the regular AMLs (82.7%, 129/156). The 11 EAMLs with atypia (40.7%, 11/27) had more nucleoli and mitotic cells compared with the 16 EAMLs without atypia (59.3%, 16/27; p<0.05). Follow-up results of 79% of cases (124/156) were obtained, and of these, only one kidney AML (0.8%, 1/124) presented with liver metastasis one year after nephrectomy. This sizeable single institutional AML series analysis revealed that the kidney and liver were the two most commonly involved organs, and most of the cases presented a benign clinical course. Few EAMLs were malignant, although adverse features including atypical mitotic figures, blood vessel invasion and tumor embolus may be significant in predicting malignant behavior.
Introduction
Angiomyolipoma (AML) is a relatively rare neoplasm, composed of variable proportions of adipose tissue, spindle and epithelioid smooth muscle-like cells and abnormal thick-walled blood vessels (1) . Most AMLs are regarded as benign in clinical course, although certain cases have been reported to be recurrent or metastatic. Approximately 30% of epithelioid AMLs (EAMLs), which are partially or entirely composed of large epithelioid cells with abundant cytoplasm, vesicular nuclei and prominent nucleoli, have malignant potential (2) . By contrast, an epithelioid morphology of the smooth muscle-like cells has been described in regular AMLs that are not associated with aggressive clinical behavior. This is analogous to the conventional description of smooth muscle neoplasm, in which epithelioid and conventional spindle cell leiomyomas exist; when referring to smooth muscle neoplasms, ʻepithelioidʼ does not necessarily indicate atypia or increased risk of malignancy (2) . Therefore, in 2010, Brimo et al proposed the concept of atypical EAMLs, and suggested that although not all EAMLs have malignant potential, certain atypical morphological features may be correlated with malignant behavior. These authors presented a predictive model of 4 atypical features, including: more than 70% atypical epithelioid cells; more than 2 mitotic figures per 10 HPF; atypical mitotic figures; and necrosis, which accurately categorized 78% of clinically malignant and 100% of clinically benign EAMLs with atypia (2). This proposal was established following an analysis of 40 cases of EAML with atypia. Whether it may be applied in general to predict malignant behavior requires further investigation. In this study, we analyzed 156 AMLs originating from different organs, which were classified into two groups (regular and epithelioid), and investigated whether the above proposal was suitable for distinguishing the cases with poor prognosis. In addition, although AMLs are mostly observed in the kidney and liver, other involved sites are sporadically reported in the hard palate (3), adrenal gland (4), anterior mediastinum (5), pancreas (6) and pelvis (7) . Whether AMLs occurring in sites other than the kidney and liver have the same clinicopathological characteristics and prognosis was also investigated.
The aims of this study were to report the affected organs and histological and biological behavior of a large series of 156 consecutive AMLs in different sites and to assess whether EAMLs with atypia may be stratified prognostically based on clinicopathological features. Classification of AMLs. In this investigation, AMLs were classified as regular, epithelioid with atypia and epithelioid without atypia according to Brimo et al (2) . Regular AMLs were diagnosed when all 3 components were readily identified (each component accounting for >10% of the tumor) and no epithelioid components were found. EAMLs were diagnosed when the epithelioid component accounted for >10% of the tumor. Epithelioid with atypia in this investigation was restricted to morphological variants of cells with an epithelioid, as opposed to a spindle cell, pattern, with abundant cytoplasm and cytological atypia, which included atypical polygonal cells, vesicular nuclei, prominent nucleoli and nuclear size that exceeded twice the size of adjacent nuclei, with moderate to severe nuclear atypia (2) . ʻEpithelioid without atypiaʼ refers to abundant cytoplasm without nuclear atypia or mitosis.
Materials and methods

Cases
Pathological parameters. Tumor size was recorded according to the largest tumor diameter in macroscopy. The percentage of the epithelioid component, nucleoli, mitosis and microscopic lymph vascular invasion was recorded. The following pathologic parameters were also evaluated: coagulative tumor necrosis, hemorrhage, multinucleated giant cells and perinephric fat invasion.
Follow-up and statistical analysis. Clinical follow-up was achieved by return visit records or telephone call. A tumor was considered malignant when there was evidence of distant metastases or local recurrence following resection. The 
Results
Involvement of AML in various sites.
The clinicopathological characteristics of the 156 AMLs are shown in Table I . The kidney and liver were the most commonly involved organs, accounting for approximately 92% of the AMLs. Other rarely involved sites and the follow-up results are shown in Table II . Of the patients with involvement of the kidney, the mean age was 46 years and the female:male ratio was 2:1. In the patients with involvement of the liver, these values were 41 years and 2.5:1, respectively. These results revealed a female and mid-age (41-60 years) morbidity predominance in both the kidney and liver cases. The average largest diameter of the tumors was 6.6 cm (range, 1-35 cm). Six of the kidney cases presented with multiple foci. Two of the cases had foci located in the bilateral kidney and the remaining four cases had multiple foci in the unilateral kidney. Of the six cases with multiple foci, three were available for a follow-up, the results of which revealed no increase in size over a period of 1-3 years.
Of the 156 AML cases, 27 were EAMLs, of which 26 were located in the kidney and one in the liver. Morphologically, the regular AMLs had three components in different proportions, including abnormal blood vessels, smooth muscle-like cells and adipose tissue. The percentage of adipose tissue, smooth muscle and epithelioid components was recorded for all AMLs in this study. We found that certain tumors consisted almost exclusively (>80%) of one component, for example adipose tissue (5 cases) or smooth muscle (2 cases). These were termed monophasic types. Of the 7 monophasic AMLs, the largest diameter ranged from 3 to 29 cm and the mean age of the patients was 46 years. None of the monophasic AMLs were recurrent or metastatic within the duration of the follow-up (12-96 months).
Correlation of AMLs and pathological parameters.
The AMLs included in this investigation were classified into two types according to cell morphological features: regular and epithelioid. The pathological parameters were compared, including necrosis, hemorrhage, mitosis, multinucleated giant cells and infiltration of perinephric fat (Table III) . This comparison revealed that epithelioid AMLs have more marked mitosis, hemorrhage and multinucleated giant cells than regular AMLs. EAMLs were also subdivided into two categories according to Brimo et al (2) : EAML without atypia and EAML with atypia. Nucleoli and mitosis were significantly more in EAML with atypia than in EAML without atypia (p<0.05).
Follow-up. The follow-up information from 124 out of the 156 AMLs was obtained. None of the cases presented with recurrence, except one case of renal EAML with atypia, which exhibited liver metastasis one year after nephrectomy. This patient was a 25-year-old female who carried a mass 15 cm in diameter in the right kidney and a swollen lymph node 5 cm in diameter between the abdominal aorta and inferior vena cava at presentation. Microscopically, the epithelioid component in this case accounted for 90% of the tumor, which was consistent with the diagnosis of EAML. Atypical features were clearly observed, including massive necrosis, nucleated or multinucleated giant cells, multiple acidophilic nucleoli, increased ratio of nucleus to cytoplasm, 4/10 HPF mitosis, multiple foci of blood vessels and perinephric fat invasion. Follow-up revealed a solid mass of size 3.5x3.5x2.0 cm in the liver 12 months later. The morphology of the liver tumor was similar to that of the kidney and a tumor embolus was observed in the liver parenchyma around the tumor. Immunohistochemical staining of the liver lesion presented HMB45 (2+), actin (3+), SMA (3+), S-100 (1+, patchy) and CD34 (-), whereas CK18, CK8, AE1/ AE3 and Hep were negative. The final diagnosis was metastatic epithelioid angiomyolipoma. (1) . A number of published case studies and small anecdotal series revealed a controversial prognosis of EAML (10-15). There was no conformity among different investigators concerning the criteria for malignancy and worse prognosis parameters in EAMLs. The generally affirmative malignant criteria included cell polymorphism, atypical features, mitosis, hemorrhage, necrosis, blood vessel and lymph node invasion and local recurrence. Other investigators considered metastasis as the only acceptable criterion in the diagnosis of a malignant AML (16) . In a study of 40 cases of EAML, Brimo et al proposed four pathological features, which are predictive of malignancy in epithelioid AML with atypia. These features were: i) ≥70% atypical epithelioid cells; ii) ≥2 mitotic figures per 10 HPF; iii) atypical mitotic figures; iv) necrosis. Additionally, these authors concluded that the presence of three or more of the above features predicts an increased risk of clinically malignant behavior. This model accurately classified 78% of the clinically malignant and 100% of the clinically benign epithelioid AMLs with atypia (2) .
In this investigation, we identified 11 atypical EAML cases according to the proposal by Brimo et al (Table IV) . Only one of the 11 atypical cases presented with metastasis. This case presented 6 atypical features including blood vessel invasion and lymph node metastasis plus the above four adverse features, as discussed by Brimo et al (2) . The other 10 cases had no recurrence or metastasis in a mean follow-up period of 42 months (range, 9-60 months), which was not consistent with the results of Brimo et al. The authors suggest that blood vessel invasion or tumor embolus is as significant as other morphological features in diagnosing atypical EAMLs. However, there were only 11 atypical EAML cases in this investigation. More cases are required in order to draw more precise conclusions.
In conclusion, AMLs mostly occur in the kidney and the liver, and most present a benign clinical course. EAMLs were few in our investigation. Adverse features, including atypical mitotic figures, blood vessel invasion and tumor embolus, may be significant in predicting malignant behavior.
